Patent · US Active

Gene upregulated in cancers of the prostate

US7928212B2 · kind B2 · utility

0Cited by
26References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 2010
Grant dateApr 19, 2011
Priority date
Expiry dateJun 16, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a novel protein designated 20P2H8 which shares homology with several heterogeneous nuclear ribonucleoproteins (hnRNPs). A full length approximately 3600 bp 20P2H8 cDNA (SEQ ID NO: 1, encoding a 517 amino acid open reading frame (SEQ ID NO: 2), is provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.